CHORD FOUNDATION
EIN: 86-2299450New Hyde Park, NYZIP: 11042
H80 - Medical Research501(c)(3)
Mission
THE OBJECTIVE OF THE CONSORTIUM FOR HARMONIZING OUTCOMES RESEARCH IN DERMATOLOGY (CHORD) IS TO PERFORM RESEARCH THAT WILL RESULT IN ACCURATE AND STANDARDIZED MEASUREMENT OF VARIOUS ASPECTS OF DISEASE IN CLINICAL TRAILS AND IN ROUTINE PRACTICE.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $843k | $0 | $888k |
Compensation
Similar Organizations
AURUM INSTITUTE USA
$718k revenueNew York, NY
Same sector (H80)Similar revenue ($718k vs $843k)Same state (New York)Similar size (8 vs 6 executives)
INTERNATIONAL SOCIETY FOR URBAN HEALTH
$924k revenueNew York, NY
Similar sector (H)Very similar revenue ($924k vs $843k)Same state (New York)Similar size (8 vs 6 executives)
LIFESPAN EXTENSION ADVOCACY FOUNDATION
$924k revenueSeaford, NY
Similar sector (H)Very similar revenue ($924k vs $843k)Same state (New York)Similar size (8 vs 6 executives)
THE HPV AND ANAL CANCER FOUNDATION
$922k revenueNew York, NY
Similar sector (H)Very similar revenue ($922k vs $843k)Same state (New York)Similar size (4 vs 6 executives)
FOOD ALLERGY FUND
$851k revenueNew York, NY
Similar sector (H)Very similar revenue ($851k vs $843k)Same state (New York)Similar size (8 vs 6 executives)
QUALITY OF LIFE IN MEMORY OF SHILOM NEUMAN
$898k revenueBrooklyn, NY
Similar sector (H)Very similar revenue ($898k vs $843k)Same state (New York)Similar size (4 vs 6 executives)
BUFFALO INSTITUTE FOR MEDICAL
$783k revenueBuffalo, NY
Similar sector (H)Very similar revenue ($783k vs $843k)Same state (New York)
Ira Sohn Conference Foundation
$769k revenueNew York, NY
Similar sector (H)Very similar revenue ($769k vs $843k)Same state (New York)
CENTRAL NEW YORK LYME AND
$487k revenueManlius, NY
Same sector (H80)Comparable revenue ($487k vs $843k)Same state (New York)
MAIMONIDES RESEARCH & DEVELOPMENT FOUNDATION
$907k revenueBrooklyn, NY
Similar sector (H)Very similar revenue ($907k vs $843k)Same state (New York)
Data from IRS Form 990 filings (2023).